12.57
2.36%
0.29
Eton Pharmaceuticals Inc Azioni (ETON) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
8.93%
7.966
|
7.313 | 7.028 | 12.00 | 5.304 |
Cost Of Revenue |
19.66%
2.959
|
3.683 | 2.625 | 2.315 | 1.958 |
Gross Profit |
37.93%
5.007
|
3.63 | 4.403 | 9.682 | 3.346 |
Operating Expenses
|
3.27%
5.807
|
5.623 | 4.951 | 5.799 | 5.88 |
Interest Income/Expense |
34.07%
0.238
|
0.361 | 0.805 | 0.273 | 0.265 |
Benefits Costs and Expenses |
5.85%
8.777
|
9.322 | 7.607 | 7.438 | 7.964 |
Costs And Expenses |
5.85%
8.777
|
9.322 | 7.607 | 7.438 | 7.964 |
Depreciation and Amortization |
8.36%
0.252
|
0.275 | 0.202 | 0.211 | 0.213 |
Operating Income/Loss |
59.86%
-0.80
|
-1.993 | -0.548 | 3.883 | -2.534 |
Nonoperating Income/Loss |
31.25%
-0.011
|
-0.016 | -0.031 | 0.676 | -0.126 |
Income/Loss From Continuing Operations Before Tax |
59.63%
-0.811
|
-2.009 | -0.579 | 4.559 | -2.66 |
Income Tax Expense/Benefit |
100.00%
-
|
0.247 | - | - | - |
Income/Loss From Continuing Operations After Tax |
64.05%
-0.811
|
-2.256 | -0.579 | 4.559 | -2.66 |
Net Income/Loss
|
64.05%
-0.811
|
-2.256 | -0.579 | 4.559 | -2.66 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
19.49%
0.0258
|
0.032 | 25.72 | 25.59 | 25.52 |
Diluted Average Shares |
0.0258
|
- | 25.72 | 25.98 | -0.034 |
Basic Earnings Per Share |
66.67%
-0.03
|
-0.09 | -0.02 | 0.18 | -100.00 |
Diluted Earnings Per Share |
-0.03
|
- | -0.02 | 0.18 | -0.11 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):